Skip to main content
Mei Wei
( out of 109 reviews )

Mei Wei, MD

Languages spoken: English

Clinical Locations

Huntsman Cancer Institute - Cancer Hospital North

2K, Plastic and Reconstructive Surgery
  • Dr. Wei Mei is specialized in breast medical oncology. Her research interests focus on clinical trials, breast cancer outcome research, epidemiology and patient's quality of life.

    Board Certification

    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Medical Oncology)

    Patient Rating

    4.9 /5
    ( out of 109 reviews )

    The patient rating score is an average of all responses on our patient experience survey. The rating averages scores for all questions about care from our providers.

    The scale on which responses are measured is 1 to 5 with 5 being the best score.

    Patient Comments

    Patient comments are gathered from our patient experience survey and displayed in their entirety.
    Patients are de-identified for confidentiality and patient privacy.

    August 13, 2023
    SUGAR HOUSE HEALTH CENTER

    Simply the best.

    August 09, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Wei genuinely cares about her patients and their health outcomes. She is always up to date on the most recent cancer research. I trust her completely.

    July 16, 2023
    SUGAR HOUSE HEALTH CENTER

    In the past, Dr. Wei found the tiny breast lump that I could not find. I trust her ability to detect a breast lump. On this visit, she listened to and validated my concerns. She offered me choices in future treatment and let me decide how I wanted to proceed. She treated me like a good friend.

    July 10, 2023
    SUGAR HOUSE HEALTH CENTER

    Dr. Mei Wei includes me in every aspect of my treatment plan with a kind and caring manner. She consults with colleagues and researches about my challenging diagnosis to figure out the best treatment plan. I highly recommend Dr. Mei Wei!

    May 27, 2023
    SUGAR HOUSE HEALTH CENTER

    She responds to any concerns in s respectful manner.

    May 25, 2023
    HUNTSMAN CANCER CENTER

    She is awesome

    May 09, 2023
    HUNTSMAN CANCER CENTER

    More details on why decisions are made would be appreciated.

    May 03, 2023
    HUNTSMAN CANCER CENTER

    Very knowledgeable and explained clearly my options. Kind

    May 02, 2023
    HUNTSMAN CANCER CENTER

    She is so kind and always listens to my concerns!

  • Dr. Wei Mei is specialized in breast medical oncology. Her research interests focus on clinical trials, breast cancer outcome research, epidemiology and patient's quality of life.

    Board Certification and Academic Information

    Academic Departments Internal Medicine -Primary
    Academic Divisions Occupational Therapy
    Board Certification
    American Board of Internal Medicine
    American Board of Internal Medicine (Sub: Medical Oncology)

    Education history

    Fellowship Hematology/Oncology - University of Utah School of Medicine Fellow
    Internal Medicine - University of Utah School of Medicine Resident
    Internship Internal Medicine - University of Nevada, Reno School of Medicine Intern
    Cancer Epidemiology - University of Utah School of Medicine Postdoctoral Research Fellow
    Residency Radiation Oncology - Sun Yat-sen University Cancer Center Resident
    Gynecological Oncology - Sun Yat-sen University Cancer Center Resident
    Professional Medical Medicine - Anhui Medical University M.D.

    Selected Publications

    Journal Article

    1. NCCN breast oncology panel (2024). NCCN clinical practice guidelines in oncology, Breast Cancer. Version 1.2024. J Natl Compr Canc Netw.
    2. Kalra M, Henry E, McCann K, Karuturi M, Bustamante JG, Parkes A, Wesolowski R, Wei M, Mougalian SS, Durm G, Qin A, Schonewolf C, Trivedi M, Armaghani AJ, Wilson FH, Iams WT, Turk AA, Vikas P, Cecchini M, Lubner S, Pathak P, Spencer K, Koshkin VS, Labriola MK, Marshall CH, Beckermann KE, theMednetorg NCI-CCC Tumor Board Program Collaborative Group, Sharifi MN, Bejjani AC, Hotchandani V, Housri S, Housri N (2022). Making National Cancer Institute- Designated Comprehensive Cancer Center Knowledge Accessible to Community Oncologists via an Online Tumor Board: Longitudinal Observational Study. JMIR Cancer.
    3. Wei M, Wang X, Zimmerman DN, Burt LM, Haaland B, Henry NL (2021). Endocrine therapy and radiotherapy use among older women with hormone receptor-positive, clinically node-negative breast cancer. Breast Cancer Res Treat, 187(1), 287-294. (Read full article)
    4. Bernard PS, Wooderchak-Donahue W, Wei M, Bray SM, Wood KC, Parikh B, McMillin GA (2021). Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer. Cancers (Basel), 13(6). (Read full article)
    5. Gilreath JA, Wei M, Paul S, Parker CJ, Stenehjem DD, Rodgers GM (2018). Dynamic dosing of romiplostim in patients with immune thrombocytopenia purpura: Two case reports. J Oncol Pharm Pract, 25(3), 719-723. (Read full article)
    6. Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB, Al-Temimi M, Lee YC, Sapkota A (2016). Household air pollution and lung cancer risk among never-smokers in Nepal. Environ Res, 147, 141-5. (Read full article)
    7. Raspanti GA, Hashibe M, Siwakoti B, Wei M, Thakur BK, Pun CB, Milrod C, Adhikari S, Lee YC, Sapkota A (2015). Ethnic Variation in Consumption of Traditional Tobacco Products and Lung Cancer Risk in Nepal. Asian Pac J Cancer Prev, 16(14), 5721-6. (Read full article)

    Case Report

    1. Wei M, Maurer KA, Henry NL (2019). Ovarian remnant syndrome in an aromatase inhibitor-treated patient with BRCA2 mutation following bilateral oophorectomy. Breast J, 25(6), 1254-1256. (Read full article)
  • News & Podcasts